PDE4D and Alzheimer disease: As non-specific inhibition of all PDE4D isoforms may cause severe adverse effects, we investigated whether specific PDE4D isoforms regulate neurite growth in HT22 cells and could serve as a more specific therapeutic target for AD treatment.